Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are wafting over the Pharmalot campus, where the official mascots are snoozing in their respective corners.
This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is wild mountain blueberry, a summer treat.
Please feel free to join us. Meanwhile, here is the latest menu of tidbits to help you get started yourself.
We hope your day is productive and meaningful. And of course, do keep in touch.
We appreciate the insights and ideas. … Eli Lilly is halving its originally planned $2.67 billion investment in the production of weight-loss syringes in Germany , Handelsblatt reports.
The reason is the announced cost-cutting law by Health Minister Nina Warken, which provides for higher discounts from pharmaceutical companies — meaning less money per medication — and stricter reimbursement rules. Furthermore, health insurance companies will be allowed to group comparable patented medicines and encourage doctors to prescribe the cheaper option.
STAT News published a clinical update in Research Highlights on 04 Jun 2026.
The item focuses on STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S.
layoffs, and more.
Review the original article for the full source wording and details.